We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Consortium Gets Mixed Reviews on Drug Industry Audits
Consortium Gets Mixed Reviews on Drug Industry Audits
September 1, 2009
The drug industry is expressing some skepticism about relying on an Rx-360 Consortium plan to conduct and share supply-chain audits, as the months-old organization sets up working groups toward that end.